Alyeska Investment Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $356K | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $18.1M | Sell |
|
|||||
|
2024
Q3 | $97.4M | Buy |
|
|||||
|
2024
Q2 | $36.7M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $52.5M | Sell |
|
|||||
|
2022
Q3 | $46.6M | Sell |
|
|||||
|
2022
Q2 | $110M | Buy |
|
|||||
|
2022
Q1 | $100M | Buy |
|
|||||
|
2021
Q4 | $52.1M | Buy |
|
|||||
|
2021
Q3 | $44.6M | Buy |
|
|||||
|
2021
Q2 | $15.3M | Sell |
|
|||||
|
2021
Q1 | $28.7M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $62.2M | Sell |
|
|||||
|
2019
Q3 | $60.8M | Buy |
|
|||||
|
2019
Q2 | $22.1M | Buy |
|
|||||
|
2019
Q1 | $15.7M | Buy |
|